Cite
HARVARD Citation
Nguyen, Y. et al. (2022). Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients. Clinical microbiology and infection. pp. 1654.e1-1654.e4. [Online].